We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Rolinco NV(BR) | LSE:RLI | London | Ordinary Share | NL0000289817 | ORD EUR1 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.00 | - |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
8 Septmber 2005, Rotterdam ROLINCO N.V. SEMIANNUAL REPORT JUNE 2005 % ROBECO CONTENTS General information 2 Report of the management board 3 Balance sheet 7 Profit and loss account 7 Cash-flow summary 8 Notes 8 Other data 13 Spread of net assets 14 GENERAL INFORMATION ROLINCO N.V. 1) (investment company with a variable capital, having its registered office in Rotterdam, the Netherlands) Coolsingel 120 Postbus 973 NL-3000 AZ Rotterdam Tel. +31- 10 - 224 12 24 Fax +31 - 10 - 411 52 88 Internet: www.robeco.com Supervisory Board Paulus C. van den Hoek Gilles Izeboud RA Johan Kremers (until 21 April 2005) Philip Lambert (as of 21 April 2005) Dirk P.M. Verbeek Management Board Arnout van Rijn Volker Wytzes Prospectus The prospectus is available at the offices of the company and via www.robeco.com. REPORT OF THE MANAGEMENT BOARD GENERAL INTRODUCTION Stock markets climb a wall of worry An old English stock-market adage is 'the market is climbing a wall of worry' and there were plenty of things to worry about in the first few months of 2005. There were concerns about rises in commodity and oil prices, a rate hike in the United States, low growth in Europe, the return of deflation in Japan, the rating downgrade of General Motors and Ford and there were concerns about growth in China. But stock prices climbed this wall of worry and helped by the advance of the US dollar against the euro, the MSCI World Index rose 11.8% in euros. Once again, most growth occurred in the United States and China. US consumers were a little discouraged by rising oil prices and higher interest rates, but they continued spending. Business confidence, however, did decrease slowly but surely. Producers faced higher wage costs, lower productivity and increasing commodity prices. The expected earnings growth decreased rapidly but growth in China remained at its usual high level and the trade surplus increased further. One detail, which is worthy of note here, is that China has become a net exporter of steel for the first time this year. Huge capital expenditure in the past few years has considerably increased production capacity so the Western steel industry had better be prepared for the worst. The old world markets of Europe and Japan are lagging. It was a particularly tough period for Europe, with difficult political situations in the European Union and in Europe's core countries Germany, France and Italy. Europe's joint monetary policy also had its limitations. While the low growth in Germany calls for a rate cut, this same rate cut may cause the Irish economy to overheat. It is however all a matter of give and take. Still, European equities outperformed their US counterparts because they are still cheaper. Japanese equities lagged but this country may well turn out to be the surprise of the second half of the year. Wages are increasing, consumer spending is positive and Japanese businesses are gradually discovering that shareholders like high dividends. Outlook The second half of 2005 will on the whole be worse than the first half. US growth will slow down as US consumers finally curb their spending. Earnings growth will decline, as the increase in commodity prices and wage costs (the latter only in the US) may lead to lower margins. But the situation will not be really bad as, however you look at it, valuations are reasonable and what is the alternative? A savings account that offers 2.5% interest? A government bond that offers 3% interest? Or a corporate bond that offers 3.5%? INVESTMENT RESULT In the first half of 2005, the share price of Rolinco rose from EUR 18.00 to EUR 20.56. Assuming reinvestment of the dividend of EUR 0.28 per share distributed in May 2005, this is an investment result of 15.9%*. On the basis of net asset value, which rose from EUR 18.12 to EUR 20.43, the investment result was 14.5%. The fund's benchmark, the S&P/Citigroup Primary Market Index Growth World (Total Return), rose 11.7% over the same period which meant that Rolinco realized a result, which exceeded the average return of growth stocks by more than 2.5%. Good stock selection was responsible for most of the outperformance although the strategic interest in emerging markets also contributed positively. It was encouraging that growth stocks kept pace with the market as a whole in the first half of 2005 after five years of relatively poor returns. The most important themes in the stock markets were: high oil prices, low bond yields, the rising housing market and the weak euro. The low bond yields were a conundrum to Fed chairman Alan Greenspan, but they did support US consumers in their debt-financing activities. An increasing number of private individuals are convinced that the price of their houses can only go one way: up. This may be a dangerous development but in view of our stable interest-rate outlook this could continue for quite some time and it does provide a solid base for the purchasing power of US consumers. In 2004, Rolinco had to deal with a headwind that grew stronger throughout the year, whereas in the first half of 2005 it has benefited from a brisk tail wind with the dollar appreciating by 11% against the euro. In the run-up to the French referendum on the European Constitution, attention shifted away from the weak dollar and the US debt problems to concerns about the euro's strength. European growth is still disappointing and the EU countries are unable to reach an agreement on a joint future. INVESTMENT POLICY Turnover in the portfolio remained limited to roughly 21% in the first half, which is appropriate for a fund with an investment horizon of three years. Our outlook for the Japanese stock market is still favorable as demonstrated by a further increase of our weight in Japan from 15% to more than 16%. A visit to the country and to several Japanese companies in Rotterdam confirmed that more attention is being paid to increasing returns and dividends but this is being done in the Japanese way which is cautiously and slowly. These developments have not yet been rewarded with strong price gains, as the Japanese market ended the reporting period virtually unchanged. The holding in emerging markets was lowered to 5% in early March. There is plenty of liquidity available in the world as a delayed result of the US accommodative monetary policy in 2004. Now that short rates are starting to rise again, money-supply growth is decreasing rapidly and in the longer term this will lead to more risk-averse behavior. Emerging markets could suffer from this but the fundamental situation remains extremely healthy: high growth, limited deficits and low market valuations. The position in the US dollar was increased to well over 50% in three steps. The consensus about the weak dollar was so great at the end of 2004 that Rolinco's slightly contrary investment strategy no longer justified an underweight in the US currency. Within the energy sector the fund benefited considerably from rising oil prices and high refining margins through its large interests in Canadian Natural Resources and Valero. Towards the end of the reporting period we started to take profits in this sector where momentum has become increasingly important. In the health-care sector large interests in drug distributor Medco Health Solutions and health insurer Wellpoint made a fine contribution. The stock of Swiss pharmaceutical company Roche also performed well in the reporting period, partly due to successes in the field of cancer treatment. Biotechnology company Elan was among the losers as it turned out that its multiple-sclerosis drug can lead to serious complications so it was temporarily withdrawn from the market. Rolinco suffered a considerable loss when it closed this position. Top 10 stocks Country Interest in % Performance in % 30/06/2005 01/01-30/06/2005 In euros In local currency 1. Total France 2.6 23.0 23.0 2. Microsoft US 2.5 5.0 -6.5 3. Roche Switzerland 2.4 25.5 25.9 4. Canadian Natural Resources Canada 2.3 90.9 73.8 5. Wellpoint US 2.0 36.0 21.1 6. Fannie Mae US 1.9 -7.1 -17.3 7. Nestl
1 Year Rolinco NV(BR) Chart |
1 Month Rolinco NV(BR) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions